740
Participants
Start Date
May 22, 2025
Primary Completion Date
December 31, 2035
Study Completion Date
December 31, 2040
EIK1001
EIK1001 is a Toll-like receptor 7/8 (TLR 7/8) dual agonist.
Pembrolizumab (KEYTRUDA® )
Pembrolizumab is a PD-1 inhibitor.
RECRUITING
Auckland City Hospital, Auckland
RECRUITING
Cliniques Universitaires Saint-Luc, Brussels
RECRUITING
The Medical Oncology Centre of Rosebank, Saxonwold
RECRUITING
Cancer Care Wollongong, Wollongong
RECRUITING
Universitair Ziekenhuis Antwerpen, Edegem
RECRUITING
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven
RECRUITING
Eastern Health, Box Hill
RECRUITING
Icon Cancer Centre Chermside, Chermside
RECRUITING
Southern Adelaide Local Health Network Incorporated Flinders Medical Centre, Bedford Park
RECRUITING
Cancercare Port Elizabeth - Langenhoven Drive Oncology Centre, Port Elizabeth
RECRUITING
TASK Eden, George Central
RECRUITING
Cape Town Oncology Trials, Cape Town
RECRUITING
Christchurch Public Hospital, Christchurch
RECRUITING
Universitätsklinikum Graz, Graz
RECRUITING
Universitätsspital Zürich, Zurich
RECRUITING
Aarhus Universitetshospital, Aarhus
RECRUITING
Algemeen Ziekenhuis Groeninge - Campus Kennedylaan, Kortrijk
RECRUITING
Aalborg University Hospital, Aalborg
RECRUITING
University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center, Pittsburgh
RECRUITING
Institut Català d'Oncologia Girona (ICO Girona), Girona
RECRUITING
Elbe Kliniken Stade-Buxtehude, Buxtehude
RECRUITING
Universitätsklinikum Schleswig-Holstein - Campus Lübeck, Lübeck
RECRUITING
Universitätsklinikum Schleswig-Holstein - Campus Kiel, Kiel
RECRUITING
GenesisCare Madrid - Hospital San Francisco de Asís, Madrid
RECRUITING
Hospital Universitario Virgen de la Victoria, Málaga
RECRUITING
Johannes Wesling Klinikum Minden, Minden
RECRUITING
Bioresearch Partner, Hialeah
RECRUITING
Centre Hospitalier Universitaire Grenoble Alpes, La Tronche
RECRUITING
Gabrail Cancer Center Research LLC, Canton
RECRUITING
IVO - Fundacion Instituto Valenciano de Oncologia, Valencia
RECRUITING
INCLIVA Instituto de Investigación Sanitaria, Valencia
RECRUITING
University of Mainz Medical Center, Mainz
RECRUITING
Washington University School of Medicine in St. Louis, St Louis
RECRUITING
Masaryk Memorial Cancer Institute, Brno
RECRUITING
Universitätsmedizin Mannheim, Mannheim
RECRUITING
Centre Hospitalier Lyon-Sud, Pierre-Bénite
RECRUITING
Universitätsklinikum Tübingen, Tübingen
RECRUITING
CHU Rouen, Rouen
RECRUITING
UCHealth Memorial Hospital Central, Colorado Springs
RECRUITING
Ironwood Cancer & Research Centers, Chandler
RECRUITING
The Oncology Institution of Hope and Innovation, Los Angeles
RECRUITING
Oulu University Hospital, Oulu
RECRUITING
Providence Medical Foundation, Santa Rosa
RECRUITING
Rabin Medical Center, Petah Tikva
RECRUITING
Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Ramat Gan
RECRUITING
Tel Aviv Medical Center, Tel Aviv
RECRUITING
Soroka medical center, Beersheba
RECRUITING
Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne, Yvoir
RECRUITING
Sunnybrook Research Ins<tute, Toronto
RECRUITING
Universitat Leipzig, Saxony
RECRUITING
Oslo University Hospital - The Norwegian Radium Hospital, Oslo
RECRUITING
Hospital da Luz Lisboa, Lisbon
RECRUITING
Hospital Universitari Dexeus, Barcelona
RECRUITING
Vall d' Hebron Institute of Oncology, Barcelona
RECRUITING
Gävle Sjukhus, Gävle
RECRUITING
Guy's and St Thomas' NHS Foundation Trust, London
RECRUITING
Sarah Cannon Research Institute London, London
Lead Sponsor
Merck Sharp & Dohme LLC
INDUSTRY
Eikon Therapeutics
INDUSTRY